Vivan Pinto departs as chief executive of Byotrol
AIM listed Byotrol, a specialist infection prevention and control company, has told the stock market this morning that Vivan Pinto, chief executive of the company, has stepped down as “to pursue other opportunities”.
TheBusinessDesk.com reported earlier this month that slower than expected growth in Europe meant the hygiene group was likely to break even this financial year – with predictions of “significant profitability” in fiscal year 2025.
Pinto joined Byotrol from Johnson & Johnson Consumer Health, where he held various roles over a 14-year career, most recently, as Area Managing Director for Africa. He had previously worked for a variety of large blue chip organisations including Pfizer and Reckitt Benckiser, both in the UK and throughout Eastern and Western Europe, India and Africa.
His previous roles have included marketing, commercial, business development, investing, and general management.
David Traynor who served as chief executive from 2013 – 2022 has “kindly agreed to act as interim CEO until a suitable replacement for Vivan is appointed” a statement said.
An investment banker by background Traynor has worked in corporate finance roles for Credit Suisse First Boston, UBS and Lehman Brothers. He ran Byotrol Consumer Products (BCP) from its inception in 2007 within his partnership role at WhatIf Ventures, moving to full time early 2012.
He led BCP to profitability in 2011 and then to the full acquisition by Byotrol plc in October 2013.
Trevor Francis, Chairman of Byotrol, commented: “From the time that Vivan took over from David Traynor as CEO, he was committed to drive forward the Company strategy and build the organisation for the exciting opportunities that we all believe are achievable. The Board thanks Vivan for all his efforts over the last 20 months and would like to wish Vivan well for the future”.
This July the AIM-listed group, based on Thornton Science Park near Chester, announced annual results that showed a fall in sales, at £4.592m, and deeper losses of £1.825m, which it said was in line with expectations.